Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.05
+0.46 (6.98%)
At close: Mar 9, 2026, 4:00 PM EDT
6.88
-0.17 (-2.41%)
After-hours: Mar 9, 2026, 7:14 PM EDT
Unicycive Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 152 | 82 | 30 | 8 | 31 | - | |
| Market Cap Growth | 139.34% | 173.36% | 270.11% | -73.58% | - | - | |
| Enterprise Value | 109 | 51 | 17 | 1 | 13 | - | |
| Last Close Price | 7.05 | 7.94 | 8.68 | 5.40 | 20.60 | - | |
| PS Ratio | - | - | 44.68 | 8.57 | - | - | |
| PB Ratio | 3.92 | 11.09 | -7.92 | -17.48 | 1.87 | - | |
| P/TBV Ratio | 4.04 | 11.09 | - | - | 1.87 | - | |
| EV/Sales Ratio | - | - | 24.77 | 1.40 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.09 | -0.21 | -0.33 | 0.02 | -0.94 | |
| Net Debt / Equity Ratio | -1.13 | -3.43 | 2.34 | 0.64 | -0.99 | -0.94 | |
| Net Debt / EBITDA Ratio | 1.35 | 0.79 | 0.43 | 0.02 | 1.81 | - | |
| Net Debt / FCF Ratio | 1.42 | 0.89 | 0.49 | 0.02 | 2.81 | -1.72 | |
| Asset Turnover | - | - | 0.08 | 0.09 | - | - | |
| Quick Ratio | 3.25 | 1.08 | 0.55 | 0.14 | 7.88 | - | |
| Current Ratio | 3.83 | 1.28 | 0.76 | 0.81 | 8.75 | 0.07 | |
| Return on Equity (ROE) | -102.29% | -2028.11% | - | -225.47% | -145.04% | - | |
| Return on Assets (ROA) | -44.22% | -87.54% | -152.67% | -104.65% | -59.22% | -1132.29% | |
| Return on Capital Employed (ROCE) | -84.20% | -425.50% | 621.40% | 3873.80% | -54.00% | 75.60% | |
| Earnings Yield | -22.05% | -44.55% | -101.28% | -221.63% | -32.48% | - | |
| FCF Yield | -19.72% | -34.75% | -60.67% | -192.11% | -18.79% | - | |
| Buyback Yield / Dilution | -167.35% | -172.97% | -62.98% | -28.96% | -37.37% | -4.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.